BTTR Stock Overview
Operates as a pet health and wellness company. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Better Choice Company Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.78 |
52 Week High | US$19.80 |
52 Week Low | US$1.58 |
Beta | 0.68 |
11 Month Change | -5.32% |
3 Month Change | -43.85% |
1 Year Change | -83.82% |
33 Year Change | -98.95% |
5 Year Change | -99.74% |
Change since IPO | -99.89% |
Recent News & Updates
Recent updates
Shareholder Returns
BTTR | US Food | US Market | |
---|---|---|---|
7D | -8.7% | -1.4% | -1.0% |
1Y | -83.8% | -0.02% | 30.3% |
Return vs Industry: BTTR underperformed the US Food industry which returned -0.4% over the past year.
Return vs Market: BTTR underperformed the US Market which returned 30.4% over the past year.
Price Volatility
BTTR volatility | |
---|---|
BTTR Average Weekly Movement | 17.0% |
Food Industry Average Movement | 5.1% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BTTR's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BTTR's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 32 | Kent Cunningham | www.betterchoicecompany.com |
Better Choice Company Inc. operates as a pet health and wellness company. Its products portfolio includes naturally formulated kibble and canned dog and cat foods, freeze-dried raw dog foods and treats, vegan dog foods and treats, oral care products and supplements, as well as toppers, dental products, and chews. The company sells its products under Halo Holistic and Halo Elevate brands.
Better Choice Company Inc. Fundamentals Summary
BTTR fundamental statistics | |
---|---|
Market cap | US$2.97m |
Earnings (TTM) | -US$13.35m |
Revenue (TTM) | US$33.52m |
0.1x
P/S Ratio-0.2x
P/E RatioIs BTTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BTTR income statement (TTM) | |
---|---|
Revenue | US$33.52m |
Cost of Revenue | US$22.60m |
Gross Profit | US$10.92m |
Other Expenses | US$24.27m |
Earnings | -US$13.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -7.32 |
Gross Margin | 32.57% |
Net Profit Margin | -39.83% |
Debt/Equity Ratio | 18.9% |
How did BTTR perform over the long term?
See historical performance and comparison